Navigation Links
Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
Date:8/19/2007

XI'AN, China, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio- Pharmaceutical Co., (OTC Bulletin Board: SKBI) ("Skystar"), a leading bio- pharmaceutical company in the People's Republic of China ("PRC"), announced its financial results for the quarter ended June 30, 2007.

Second Quarter 2007 Highlights

-- Revenue increased 22% year-over-year to $3.4 million

-- Gross margin increased to 58.2% from 45.5% in Q2 2006

-- Operating income increased 90% year-over-year to $1.2 million

-- Adjusted non-GAAP net income increased 59.5% to $771,041

-- Gained approval for 49 new veterinary medicines and opened 150 Skystar

franchise stores

"Our commitment this year to enhancing our production, marketing and R&D efforts are validated through our strong financial results in the second quarter," commented Mr. Weibing Lu, Chairman and Chief Executive Officer of Skystar Bio-Pharmaceutical. "We have dedicated significant resources this year to broadening our product offering and building a solid distribution network supported by an in-depth customer training and education program. We believe this strategy will support continued revenue and net income growth in the future."

Revenue for the second quarter of 2007 was $3.4 million, up 22% from $2.8 million in the second quarter of 2006. The increase in revenue was due to the launching of ten new veterinary medicines and enhanced marketing and advertising efforts. For the second quarter of 2007, revenue from veterinary medicine grew 34% to $1.5 million from $1.1 million in the same period a year ago. Veterinary medicines and microorganisms represented the majority of revenue accounting for 45% and 39% of total revenue, respectively. Vaccines contributed approximately 5% of revenue and feed additives represented the remaining 11%.

Gross profit for the second quarter of 2007 was $2.0 million, up 56% from $1.3 million in the second quarter of 2006. Gross margin in the s
'/>"/>

SOURCE Skystar Bio-Pharmaceutical Co.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 Dr. Ingrid Warmuth and Anamaria Newport, ... are proud to announce an Open House at their Swedesboro ... Saturday, June 8th from 10 AM to 2 PM. ... PA-C and staff will be on hand to talk to ... treatments, and provide complimentary cosmetic consultations. There will also be ...
(Date:5/24/2013)... and TEL AVIV, Israel , ... or the "Company") (NYSE MKT: NSPR), a leader in embolic ... the Company,s President and Chief Executive Officer, and ... participate in the Benchmark Company, LLC One-on-One Investor Conference on ... Wisconsin Ave., Milwaukee, WI. ...
(Date:5/24/2013)... May 24, 2013 Many factors impact ... uptake or efflux transporters at the blood-tissue barrier. Even ... to unbound fractions in the tissue rather than the ... disposition challenges is required to guide lead optimization, predict ... any species-dependent variables that may impact the likely human ...
(Date:5/24/2013)... May 24, 2013 Quincy Bioscience, ... and development of calcium-binding proteins to support healthy ... safety assessment study of apoaequorin in ... published for the British Industrial Biological Research Association. ... to investigate potential adverse effects, if any, of ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2
... Worcester, MA June 11, 2009 (EurekAlert)--Advanced Cell Technology, ... today the long-term safety and efficacy of human ... produced under manufacturing conditions suitable for human clinical ... the use of RPE for the treatment of ...
... Council for American Medical Innovation Unveils Policy Agenda at ... WASHINGTON, June 12 Political leaders and health policy, ... at the Newseum in Washington, D.C., to address the ... at the "Best & Brightest Forum on Medical Innovation: ...
... June 12 /PRNewswire-Asia-FirstCall/ -- Domain,Registration Corp. (OTC Bulletin ... process of changing its name to "BioPharm Asia ... Liaoning Provinces, through its,subsidiary Tonghua Shengantang Medical & ... chain drugstores are strategically located in the following ...
Cached Biology Technology:Assessment of safety and efficacy of human embryonic stem cell therapy 2Assessment of safety and efficacy of human embryonic stem cell therapy 3Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving 'Recovery Through Discovery' 2Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving 'Recovery Through Discovery' 3Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving 'Recovery Through Discovery' 4Domain Registration Corp ("BioPharm Asia, Inc") Opens 360 New Drugstores in Jilin and Liaoning Provinces 2
(Date:5/24/2013)... studying noise in one French Quarter neighborhood of New ... municipal ordinances, Annette Hurley, PhD, Assistant Professor of Audiology ... Arriaga, a third-year LSUHSC doctor of audiology student, recommend ... hearing health. Their case study is published online in ... Management ., "An important part of an audiologist,s practice ...
(Date:5/23/2013)... world,s most popular fruit, can be made both better-tasting ... varieties. , "Working with GM tomatoes that are ... a specific compound, allows us to pinpoint exactly how ... from the John Innes Centre. , The research could ... and shelf life characteristics because even higher levels of ...
(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... way to create electromagnetic Terahertz (THz) waves or T-rays - ... study, published recently in the journal Nature Photonics , ... could be used to make better medical scanning gadgets and ... scanner used in Star Trek. In the study, researchers ...
... The Presidential Commission for the Study of Bioethical ... San Francisco, CA. Following its report on ... projects: medical countermeasures for children, whole genome sequencing and ... Jan. 10, Secretary of Health and Human Services Kathleen ...
... amount of fat they carry around depending on their species, ... this variation have been a mystery. The Bristol study ... strategies animals employ to avoid two causes of death: starvation ... often exert opposite pressures on animals, for example, storing lots ...
Cached Biology News:T-rays technology could help develop Star Trek-style hand-held medical scanners 2T-rays technology could help develop Star Trek-style hand-held medical scanners 3Bioethics commission to meet in February in San Francisco 2Why bats, rats and cats store different amounts of fat 2
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
... 4 deuterium atoms at the 9, 10, 12, ... as an internal standard for the quantification of ... produced by the lipoxygenation of linoleic acid in ... in atherosclerotic plaques, as an esterified component of ...
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: